MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/crd.0000000000001327

Медицинская библиотека · Cardiology in review · 2026

Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted Interventions.

Thukral Jatin, Sindhwani Ninaad, Khan Kuldeep, Moudgil Pyush, Singla Rohan, Garg Khushi, Shah Riya Kaushal, Kaur Harbir, Thukral Nikhil, Agrawal Siddharth Pravin, Frishman William H, Aronow Wilbert S

СтатьяПеревод в очереди

Аннотация

Chimeric antigen receptor T-cell therapy has revolutionized the treatment of hematological malignancies but is associated with significant immune-mediated toxicities, particularly cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, driven by an exaggerated inflammatory response involving cytokines such as interleukin (IL)-6, IL-1, and tumor necrosis factor-alpha. These processes contribute to endothelial dysfunction and a spectrum of cardiovascular complications, including hypotension, arrhythmias, myocardial dysfunction, and heart failure. The underlying pathophysiology involves complex interactions between immune activation and vascular injury, often progressing rapidly and necessitating early recognition. Contemporary management is shifting from reactive treatment to proactive strategies, emphasizing early risk stratification using clinical parameters, biomarkers, and imaging, alongside timely intervention with cytokine-directed therapies such as IL-6 and IL-1 inhibitors. Integration of cardiology within multidisciplinary care teams is essential for optimizing outcomes through tailored monitoring and management of cardiovascular complications. As chimeric antigen receptor T-cell therapy expands to broader and higher-risk populations, including those with pre-existing cardiovascular disease, a structured cardio-oncology approach and further prospective research are critical to improving safety and long-term outcomes.

Для цитирования: Thukral Jatin, Sindhwani Ninaad, Khan Kuldeep, Moudgil Pyush, Singla Rohan, Garg Khushi, Shah Riya Kaushal, Kaur Harbir, Thukral Nikhil, Agrawal Siddharth Pravin, Frishman William H, Aronow Wilbert S. Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted Interventions.. Cardiology in review. 2026. DOI: 10.1097/crd.0000000000001327.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.